Updated

A Smithsonian Magazine feature reported on November 13, 2026, that GLP-1 drugs may help with conditions beyond weight loss, including addiction, dementia and cancer. The drugs appear to act on the brain's reward circuitry and help regulate inflammation, but much of the research is preliminary and clinical trials are needed.